Testimony of Harold E. Varmus, M.D., Director, National Institutes of Health Before the Subcommittee on Human Resources and Intergovernmental Relations Committee on Government Reform and Oversight, United States House of Representatives

Whose Responsibility Is The Protection of Human Subjects of Research? Who is involved in protecting human subjects? The architecture of the current system involves at least half a dozen levels of protection. Ultimately, protection depends on several factors. First, the clinical investigator must be scientifically well-trained and also aware of his or her ethical responsibilities as a researcher, and committed to both the advancement of knowledge and the welfare of research participants. The initial planning of the research protocol is a vital part of the protection of human subjects, during which time the researchers perform a thorough review of the literature in order to develop a research plan and also to identify and articulate any potential risks associated with the research. The investigators must consider both benefits and risks associated with the research, build in safeguards for research participants, and formulate an extensive process to inform potential participants, to obtain informed consent for participation, and to document the consent. Second, there is review and approval of the research protocol by a local IRB, a requirement of the DHHS regulations for Federally-supported research. Although non-Federal research is not covered by these regulations, you should be aware that the DHHS regulations are in general use by others as well. Many institutions voluntarily follow DHHS regulations for all their research. Following IRB review, additional review responsibilities rest with 1) the executive official of the research site; 2) the scientific review group at the NIH (generally, within the Division of Research Grants, or within an NIH Institute or Center [IC]); 3) the Advisory Council or Board of the funding IC; and 4) the executive official of the funding entity. Each has the authority to raise concerns about human subjects issues and to request further evaluation and correction of any problems found. Once multiple review of the proposed study design and informed consent documents has been accomplished, and the proposal is funded, there is the crucial interaction between the research volunteer and the research investigator. It is at this point that the informed consent process begins -- when the research volunteer is apprised of what will be required for his/her participation in the study, including known associated risks. The informed consent document is only one component--the written component--of the informed consent process. I will describe the particulars of informed consent later. There also may be several individuals involved with the research volunteer during the process of obtaining informed consent, and throughout the course of the study, such as the nursing and scientific staff, as well as a physician. There also may be a consent auditor or monitor, or an advocate for the research subject to ensure that research subjects understand and are kept informed of any risks or proposed changes. Role of the IRB The role of the IRB is to protect the rights and safeguard the welfare of human research subjects. As I mentioned earlier. IRB review is required by DHHS regulations. The IRB must be established at the local level and have a minimum of five people, including at least one scientist, one nonscientist, and one person not otherwise affiliated with the institution conducting 2

/ 12

Actions

file_download Download Options Download this page PDF - Pages #1-12 Image - Page 2 Plain Text - Page 2

About this Item

Title
Testimony of Harold E. Varmus, M.D., Director, National Institutes of Health Before the Subcommittee on Human Resources and Intergovernmental Relations Committee on Government Reform and Oversight, United States House of Representatives
Author
Varmus, Harold
Canvas
Page 2
Publication
1997-05-08
Subject terms
testimonies
Item type:
testimonies

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0418.029
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0418.029/3

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0418.029

Cite this Item

Full citation
"Testimony of Harold E. Varmus, M.D., Director, National Institutes of Health Before the Subcommittee on Human Resources and Intergovernmental Relations Committee on Government Reform and Oversight, United States House of Representatives." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0418.029. University of Michigan Library Digital Collections. Accessed June 7, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.